About Relugolix API
Therapeutic CategoryAnti-Cancer/ Oncology

CAS Number
737789-87-6
API Technology
Synthetic
Dose Form
Oral Solid/Tablets, Injectable
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, Brazil DMF
Mechanism of Action
Relugolix is a nonpeptide GnRH receptor antagonist that competitively binds to pituitary GnRH receptors, thereby, reducing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and consequently testosterone.
Indication
ORGOVYX is a gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment of adult patients with advanced prostate cancer.
Related APIs
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!